187 related articles for article (PubMed ID: 33823169)
21. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
[TBL] [Abstract][Full Text] [Related]
22. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
Pulsipher MA; Chitphakdithai P; Logan BR; Navarro WH; Levine JE; Miller JP; Shaw BE; O'Donnell PV; Majhail NS; Confer DL
Blood; 2014 Jun; 123(23):3655-63. PubMed ID: 24735965
[TBL] [Abstract][Full Text] [Related]
23. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
Yanagisawa R; Hirakawa T; Doki N; Ikegame K; Matsuoka KI; Fukuda T; Nakamae H; Ota S; Hiramoto N; Ishikawa J; Ara T; Tanaka M; Koga Y; Kawakita T; Maruyama Y; Kanda Y; Hino M; Atsuta Y; Yabe H; Tsukada N
Int J Hematol; 2023 Mar; 117(3):421-427. PubMed ID: 36403180
[TBL] [Abstract][Full Text] [Related]
24. Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening.
Nacheva E; Ahyee T; Addada J; Navarette C; Pamphilon D; Regan F; Pawson R; Szydlo R; Goldman J; Mackinnon S; Shaw BE; Madrigal A
Bone Marrow Transplant; 2020 Jul; 55(7):1290-1296. PubMed ID: 32440014
[TBL] [Abstract][Full Text] [Related]
25. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with bone marrow stem cell yield for pediatric allogeneic stem cell transplantation: The impact of donor characteristics.
Fettah A; Özbek N; Özgüner M; Azık F; Işık P; Avcı Z; Yaralı N; Uçkan D; Tunç B
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27813281
[TBL] [Abstract][Full Text] [Related]
27. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
[TBL] [Abstract][Full Text] [Related]
28. [A Single-Center Analysis of the Use of G-CSF Combined with Plerixafor to Mobilize Peripheral Blood Hematopoietic Stem Cell from Healthy Related Donors in Allogeneic Hematopoietic Stem Cell Transplantation].
Chen J; Yuan LL; Zhang X; Qiao JL; Yin QX; Zhang YM; Yang XL; Cao XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):286-291. PubMed ID: 35123641
[TBL] [Abstract][Full Text] [Related]
29. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.
Vasu S; Leitman SF; Tisdale JF; Hsieh MM; Childs RW; Barrett AJ; Fowler DH; Bishop MR; Kang EM; Malech HL; Dunbar CE; Khuu HM; Wesley R; Yau YY; Bolan CD
Blood; 2008 Sep; 112(5):2092-100. PubMed ID: 18523146
[TBL] [Abstract][Full Text] [Related]
30. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim.
Moncada V; Bolan C; Yau YY; Leitman SF
Transfusion; 2003 Apr; 43(4):495-501. PubMed ID: 12662283
[TBL] [Abstract][Full Text] [Related]
31. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
32. Application of peripheral blood stem cells (PBSC) mobilized by recombinant human granulocyte colony stimulating factor for allogeneic PBSC transplantation and the comparison of allogeneic PBSC transplantation and bone marrow transplantation.
Kasai M; Kiyama Y; Kawamura A
Transfus Apher Sci; 2002 Apr; 26(2):121-7. PubMed ID: 12121068
[TBL] [Abstract][Full Text] [Related]
33. Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.
Gordon SV; Nivison-Smith I; Szer J; Chapman JR
Intern Med J; 2013 Nov; 43(11):1183-90. PubMed ID: 24007325
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Shaw BE; Logan BR; Kiefer DM; Chitphakdithai P; Pedersen TL; Abdel-Azim H; Abidi MH; Akpek G; Diaz MA; Artz AS; Dandoy C; Gajewski JL; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Majhail NS; O'Donnell PV; Olsson RF; Savani BN; Schears RM; Stroncek DF; Switzer GE; Williams EP; Wingard JR; Wirk BM; Confer DL; Pulsipher MA
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1830-8. PubMed ID: 26116089
[TBL] [Abstract][Full Text] [Related]
35. Favorable recovery profiles and good reliability among youngest unrelated stem cell donors supports lowering the minimum donor registration age.
Ros-Soto J; Pryce A; Zoubek E; Burlton C; Szydlo R; Anthias C
J Clin Apher; 2023 Oct; 38(5):562-572. PubMed ID: 37309733
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.
Switzer GE; Bruce JG; Harrington D; Haagenson M; Drexler R; Foley A; Confer D; Bishop M; Anderlini P; Rowley S; Leitman SF; Anasetti C; Wingard JR
Biol Blood Marrow Transplant; 2014 Jan; 20(1):118-27. PubMed ID: 24184336
[TBL] [Abstract][Full Text] [Related]
37. Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest.
Lown RN; Tulpule S; Russell NH; Craddock CF; Roest R; Madrigal JA; Shaw BE
Haematologica; 2013 Dec; 98(12):1956-63. PubMed ID: 23812935
[TBL] [Abstract][Full Text] [Related]
38. Is It Possible to be a Stem Cell Donor for the Second Time: A Single-Center Report of 12 Consecutive Procedures.
Kozanoglu I; Buyukkurt N; Asma S; Ucmak H; Yeral M; Kis C; Boga C; Ozdogu H
Exp Clin Transplant; 2021 Oct; ():. PubMed ID: 34763626
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.
Hölig K; Kramer M; Kroschinsky F; Bornhäuser M; Mengling T; Schmidt AH; Rutt C; Ehninger G
Blood; 2009 Oct; 114(18):3757-63. PubMed ID: 19666868
[TBL] [Abstract][Full Text] [Related]
40. Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.
De la Rubia J; Arbona C; Del Cañizo C; Arrieta R; De Arriba F; Pascual MJ; Sanjuan I; Díaz MA; Brunet S; Alegre A; Insunza A; Espigado I; Zamora C; De la Serna J; Serrano D; Bargay J; Petit J; Martínez D; Verdeguer A; Ribera JM; Martínez C; Benlloch L; Sanz MA
J Hematother Stem Cell Res; 2002 Aug; 11(4):705-9. PubMed ID: 12201959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
